KaydedilenlerDerginizi ekleyin

Dergiler / BEYOGLU EYE JOURNAL / 2020 / Cilt: 5 - Sayı: 2

Histopathological Evaluation of Pterygium Patients with Type 2 Diabetes Mellitus

Ozgur EROGUL
Leyla ERYİGİT EROGUL
Nilay SEN KORKMAZ
Fatih CELİK
MUSTAFA DOĞAN
Hamidu HAMİSİ GOBEKA
Sayfa
122–128
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Conclusion: There was no histopathological difference in the pterygium tissue in patients with DM.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: The aim of this study was to histopathologically compare patients with and without diabetes mellitus who underwent pterygium excision.
📊
Temel Bulgular & Veri:Methods: In this retrospective case-control study, 60 patients with a history of pterygium excision were divided into 2 groups: those with DM and those without DM.
💡
Sonuç & Katkı:Conclusion: There was no histopathological difference in the pterygium tissue in patients with DM.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: The aim of this study was to histopathologically compare patients with and without diabetes mellitus who underwent pterygium excision. Methods: In this retrospective case-control study, 60 patients with a history of pterygium excision were divided into 2 groups: those with DM and those without DM. Histopathological findings (squamous metaplasia, dysplasia, inflammation, fibrinoid changes, and vascularization) were compared. Results: The mean age of the 60 patients (females, 54.5%) included in the study was 58.6±12.8 years. The mean age was 53.7±13.7 years in the patients with DM and 63.6±9.6 years in the patients without DM. There were no significant differences in the excised pterygium tissues in terms of squamous metaplasia, dysplasia, fibrinoid changes, inflammation, or vascularization. Conclusion: There was no histopathological difference in the pterygium tissue in patients with DM.

🔖

Bu Makaleye Atıf Yap

EROGUL, O., EROGUL, L. E., KORKMAZ, N. S., CELİK, F., DOĞAN, M., GOBEKA, H. H. (2020). Histopathological Evaluation of Pterygium Patients with Type 2 Diabetes Mellitus. BEYOGLU EYE JOURNAL, Cilt: 5 - Sayı: 2, 122–128. https://ajindex.com/articles/142052

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Kase S, Takahashi S, Sato I, Nakanishi K, Yoshida K, Ohno S. Expression of p27(KIP1) and cyclin D1, and cell proliferation in human pterygium. Br J Ophthalmol 2007;91:958–61
  2. Bradley JC, Yang W, Bradley RH, Reid TW, Schwab IR. The science of pterygia. Br J Ophthalmol 2010;94:815–20
  3. Chowers I, Pe'er J, Zamir E, Livni N, Ilsar M, Frucht-Pery J. Proliferative activity and p53 expression in primary and recurrent pterygia. Ophthalmology 2001;108:985–8
  4. Yang SF, Lin CY, Yang PY, Chao SC, Ye YZ, Hu DN. Increased expression of gelatinase (MMP-2 and MMP-9) in pterygia and pterygium fibroblasts with disease progression and activation of protein kinase C. Invest Ophthalmol Vis Sci 2009;50:4588–96
  5. Gharaee H, Shayegan MR, Khakzad MR, Kianoush S, VarastehAR, Sankian M, et al. The expression of vascular endothelial growth factor in pterygium tissue of atopic patients. Int Ophthalmol 2014;34:1175–81
  6. Alba-Loureiro TC, Munhoz CD, Martins JO, Cerchiaro GA, Scavone C, Curi R, et al. Neutrophil function and metabolism in individuals with diabetes mellitus. Braz J Med Biol Res 2007;40:1037–44
  7. Onitilo AA, Engel JM, Glurich I, Stankowski RV, Williams GM, Doi SA. Diabetes and cancer I: risk, survival, and implications for screening. Cancer Causes Control 2012;23:967–81
  8. Džunić B, Jovanović P, Veselinović D, Petrović A, Stefanović I, Kovačević I. Analysis of pathohistological characteristics of pterygium. Bosn J Basic Med Sci 2010;10:307–13
  9. Chui J, Coroneo MT, Tat LT, Crouch R, Wakefield D, Di Girolamo N. Ophthalmic pterygium: a stem cell disorder with premalignant features. Am J Pathol 2011;178:817–27
  10. Chui J, Di Girolamo N, Wakefield D, Coroneo MT. The pathogenesis of pterygium: current concepts and their therapeutic implications. Ocul Surf 2008;6:24–43
  11. Asokan R, Venkatasubbu RS, Velumuri L, Lingam V, George R. Prevalence and associated factors for pterygium and pinguecula in a South Indian population. Ophthalmic Physiol Opt 2012;32:39–44
  12. Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP. Diabetes mellitus and inflammation. Curr Diab Rep 2013;13:435–44
  13. Mimura T, Obata H, Usui T, Mori M, Yamagami S, Funatsu H, et al. Pinguecula and diabetes mellitus. Cornea 2012;31:264–8
  14. Kaji Y, Oshika T, Amano S, Okamoto F, Koito W, Horiuchi S. Immunohistochemical localization of advanced glycation end products in pinguecula. Graefes Arch Clin Exp Ophthalmol 2006;244:104–8
  15. Shera AS, Jawad F, Maqsood A, Jamal S, Azfar M, Ahmed U. Preval